1. Home
  2. FTRE vs CGBD Comparison

FTRE vs CGBD Comparison

Compare FTRE & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • CGBD
  • Stock Information
  • Founded
  • FTRE 1996
  • CGBD 2012
  • Country
  • FTRE United States
  • CGBD United States
  • Employees
  • FTRE N/A
  • CGBD N/A
  • Industry
  • FTRE Medical Specialities
  • CGBD Finance: Consumer Services
  • Sector
  • FTRE Health Care
  • CGBD Finance
  • Exchange
  • FTRE Nasdaq
  • CGBD Nasdaq
  • Market Cap
  • FTRE 864.4M
  • CGBD 881.4M
  • IPO Year
  • FTRE N/A
  • CGBD 2017
  • Fundamental
  • Price
  • FTRE $9.88
  • CGBD $11.66
  • Analyst Decision
  • FTRE Hold
  • CGBD Hold
  • Analyst Count
  • FTRE 9
  • CGBD 6
  • Target Price
  • FTRE $13.31
  • CGBD $13.70
  • AVG Volume (30 Days)
  • FTRE 1.4M
  • CGBD 518.1K
  • Earning Date
  • FTRE 11-05-2025
  • CGBD 11-04-2025
  • Dividend Yield
  • FTRE N/A
  • CGBD 14.13%
  • EPS Growth
  • FTRE N/A
  • CGBD N/A
  • EPS
  • FTRE N/A
  • CGBD 1.14
  • Revenue
  • FTRE $2,759,900,000.00
  • CGBD $245,008,000.00
  • Revenue This Year
  • FTRE $0.47
  • CGBD $15.09
  • Revenue Next Year
  • FTRE N/A
  • CGBD $5.69
  • P/E Ratio
  • FTRE N/A
  • CGBD $10.26
  • Revenue Growth
  • FTRE 1.88
  • CGBD 2.55
  • 52 Week Low
  • FTRE $3.97
  • CGBD $11.64
  • 52 Week High
  • FTRE $25.05
  • CGBD $18.64
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 45.63
  • CGBD 33.47
  • Support Level
  • FTRE $10.89
  • CGBD $11.77
  • Resistance Level
  • FTRE $12.07
  • CGBD $12.26
  • Average True Range (ATR)
  • FTRE 0.97
  • CGBD 0.28
  • MACD
  • FTRE -0.13
  • CGBD -0.04
  • Stochastic Oscillator
  • FTRE 10.15
  • CGBD 1.45

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: